Fasken Martineau DuMoulin advised Research Capital Corporation. PyroGenesis Canada Inc. (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY) (“PyroGenesis”) announced that it has closed its previously announced “best-efforts” brokered private placement...
PyroGenesis Canada Inc.’s C$3 Million Brokered Private Placement of Convertible Debenture Units
BULGOD Inc.’s C$2.2 Million Private Placement
Fasken Martineau DuMoulin LLP advised BULGOLD Inc. in the transaction. BULGOLD Inc. (the “Company”) announced it has closed an approximately C$2.2 million ($1.67 million) non-brokered private placement offering...
Real Estate Split Corp.’s C$10.3 Million Shares Public Offering
Fasken Martineau DuMoulin LLP advised Middlefield Limited in the offering. Real Estate Split Corp. (TSX: RS and RS.PR.A) (the “Fund”) announced that it completed an overnight...
Trigon Metals’ C$5 Million Private Placement
Fasken Martineau DuMoulin LLP advised Beacon Securities Limited in the transaction. Trigon Metals Inc. announced its brokered private placement offering of 25,000,000 units at a price of...
Steppe Gold Ltd.’s Acquisition of Anacortes Mining Corp.
Fasken Martineau DuMoulin LLP advised Steppe Gold Ltd. in the transaction. Steppe Gold Ltd. (“Steppe”) announced that it has completed its acquisition of Anacortes Mining Corp. pursuant...
E Split Corp.’s C$33.3 Million Shares Public Offering
Fasken Martineau DuMoulin LLP advised Middlefield Limited in the transaction. E Split Corp. (TSX: ENS and ENS.PR.A) (the “Fund”) announced that it has completed an overnight public offering...
Altis Labs’ C$7.9 Million Seed Funding Round
Fasken Martineau DuMoulin LLP advised Debiopharm Innovation Fund in the transaction. Altis Labs Inc. announced the closing of its C$7.9 million ($6 Million) seed funding round co-led by...
EBRD’s $81.5 Million Strategic Investment in Eldorado
Fasken acted as Canadian counsel to Eldorado on the deal. The European Bank for Reconstruction and Development (“EBRD”) announced a $81.5 Million Strategic Investment in Eldorado.The Concurrent Private...
Algernon Pharmaceuticals’ C$1.1 Million Rights Offering
Fasken represented Research Capital Corporation in the offering. Algernon Pharmaceuticals Inc. (“Algernon” or “the Company”), a Canadian clinical stage pharmaceutical development company, completed a rights offering...
First Quantum Minerals’ US$1.3 Billion Senior Notes Offering
Fasken advised First Quantum on the offering. First Quantum Minerals Ltd. announced its upsized offering of US$1.3 billion aggregate principal amount of 8.625% Senior Notes due 2031....
Delta Resources’ C$10 Million Private Placement
Fasken advised the Delta Resources, while Cassels acted for the underwriters in the transaction. Delta Resources Limited closed a “bought deal” private placement of (i) 7,143,000...
Eastern Resources’ Qualifying Transaction with St Charles Resources Inc.
Fasken Martineau DuMoulin LLP assisted Eastern Resources on the deal. St Charles Resources Inc., a capital pool company listed on the TSX Venture Exchange, completed its qualifying transaction with...